The analytical gap: what market data show
The gap between declared and actual quality can be enormous for compounds sold outside regulated channels. In a peer-reviewed market-surveillance study (Ashraf et al., 2024), samples of semaglutide purchased from online sellers without a prescription were measured at 7.7% to 14.37% purity, even though labels claimed 99%. Active content also deviated from the stated amount by 28.56–38.69%, and endotoxin was detected in every sample. This was not a one-off but a documented pattern; the analysis used liquid chromatography coupled with mass spectrometry. For a researcher the lesson is clear: a number printed on a label, without independent analytical confirmation, tells you nothing reliable about the true identity and purity of the compound in the vial.
Red flag: no independent per-batch COA
The first red flag is the absence of an independent Certificate of Analysis (COA) for each individual batch. Some sellers post a single generic COA and reuse it across products for months or years. Every peptide synthesis is its own batch with its own impurity profile, so a generic or inherited COA does not reflect the contents of your specific vial. A good answer looks like this: the exact lot you receive has a fresh COA with a matching batch number, a test date, and the name of the testing lab. If a seller has no COA, will not show it before purchase, or offers only an image with no traceable data, treat that as a serious quality-control warning.
Red flag: purity not confirmed by HPLC and mass spectrometry
The second red flag is purity that is not confirmed by two complementary methods — high-performance liquid chromatography (HPLC) and mass spectrometry (MS). HPLC tells you what fraction of the total peptide material is the target sequence (purity, expressed as % of peak area), while MS confirms identity through an accurately measured molecular mass and, where needed, sequence via MS/MS fragmentation (McCarthy et al., 2023). A bare '99%' claim with no accompanying chromatogram or mass spectrum is not verifiable. Solid-phase synthesis routinely generates truncated and deletion products and side-reaction by-products; without HPLC and MS these impurities cannot be detected or quantified. Look for raw chromatograms and disclosed methodology, not just a final percentage.
Red flag: no batch or lot traceability
The third red flag is a lack of batch or lot traceability. A trustworthy product carries a unique batch number that ties the physical vial to its COA, its analysis date, and ideally a unique code for online verification. Traceability lets you attribute the result you obtain in the lab to one specific production batch — the foundation of experimental reproducibility. When a vial has no lot marking, when the number on the packaging does not match the documentation, or when one COA 'covers' several different lots, the chain of evidence is broken. Peptide reference standards require a level of characterization beyond basic tests precisely so that each batch is unambiguously defined and documented (McCarthy et al., 2023).
Red flag: mislabeled product, anonymous seller, suspicious price
The fourth cluster of red flags concerns the product and the seller themselves. A mislabeled, substandard, or underdosed material — where actual content and identity do not match the label — is exactly what market studies of online sales have found (Ahmed et al., 2022; Ashraf et al., 2024). Equally concerning is an anonymous seller with no company name, registration, physical address, or contact details: with no legal entity there is no accountability for quality. Price is also a signal — a value far below the market often reflects more cheaply synthesized material with a poorer impurity profile, skipped testing, or outright counterfeiting. Low price, anonymity, and missing documentation tend to appear together; treat them as one connected set of warnings, not separate trivialities.
How a public COA and an independent lab protect the researcher
A public COA and an independent third-party lab together form an objective protection for the researcher. 'Independent' means the analysis is not performed by the seller but by a separate, impartial lab, which removes the conflict of interest. 'Public' means the certificate is available before purchase and can be linked to the exact batch. In counterfeit detection, no single method is sufficient — combining orthogonal techniques yields a more reliable result (McCarthy et al., 2023). A COA that includes an HPLC chromatogram with peak integration, a mass spectrum with a measured molecular mass, a batch number, and a test date lets a researcher verify identity and purity before the material enters an experiment, and secures the traceability and reproducibility of results.
Research use only and quality
All products are intended strictly for research use only (RUO) and for in vitro or laboratory use. They are not intended for human or veterinary use, are not medicines, and must not be used to diagnose, treat, or prevent any condition. This article is educational and does not constitute medical or professional advice. As a practical quality standard, peptid.si provides laboratory-verified purity for every batch through a public Certificate of Analysis (COA) available in the COA Vault — with a matching batch number, HPLC and mass spectrometry results, and a test date — so that a researcher can confirm identity and purity before use.
References / Links
- Ashraf AR, Mackey TK, Vida RG, Kulcsár G, et al. (2024). Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study. Journal of Medical Internet Research. PubMed
- McCarthy D, Han Y, Carrick K, Schmidt D, et al. (2023). Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharmaceutical Research. SpringerLink
- Ahmed J, Modica de Mohac L, Mackey TK, Raimi-Abraham BT (2022). A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives. Journal of Medicine Access. PubMed
